{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011680","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.253415+00:00","generated_at":"2026-05-17T17:31:03.672570+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Processa raises $1.3M in private placement; evaluating crypto treasury strategy","bullets":["Sold 5,467,181 restricted shares at $0.23/share for ~$1.3M gross proceeds.","Placement agent LifeSci Capital receives 7% cash fee; offering closed August 6, 2025.","Net proceeds for general corporate purposes; company evaluating corporate cryptocurrency treasury strategies.","Crypto strategy aims to diversify capital base, reduce dilution, and fund clinical programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011680","json":"https://secwatch.observer/filing/0001493152-25-011680.json","markdown":"https://secwatch.observer/filing/0001493152-25-011680.md","text":"https://secwatch.observer/filing/0001493152-25-011680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225011680/0001493152-25-011680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225011680/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:31:03.672570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}